Diagnostics
MTB susceptibility testing by blood agar can be used in resource-limited areas
Published in TB and Outbreaks Week, May 23rd, 2006
In a recent study, researchers in Turkey conducted a study to "evaluate the performance of blood agar for the susceptibility testing of 50 Mycobacterium tuberculosis clinical isolates against isoniazid (INH), rifampicin (RMP), streptomycin (SM) and ethambutol (EMB).
"The activity of the drugs was determined by the proportion method on blood agar instead of Middlebrook 7H10 agar according to Clinical Laboratory Standard Institute recommendations."
According to A.Y. Coban and colleagues at Ondokuz Mayis...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Campylobacter Outbreaks
Long-lasting gastroenteritis outbreak associated with Campylobacter milk contamination - Legionellosis Outbreaks
Legionella pneumophila serogroup 5 cause of Legionnaire disease outbreak - Neonatal Ocular Herpes Infection
Genital herpes epidemic likely to cause increase in neonatal ocular herpes - Rhodotorula Mucilaginosa Outbreaks
Rhodotorula mucilaginosa outbreak identified in neonatal intensive care unit - Anthrax Histopathology
Murine model reproduces human histopathology of anthrax - Avian Influenza
Rapid response stockpile of Tamiflu now ready and available to the World Health Organization - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
